|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Restricted cash, current | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Prepaid expenses | |||||||||||||||||||
| Accounts receivable | |||||||||||||||||||
| Inventory | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Investments held in Trust Account | |||||||||||||||||||
| Cash held in Trust Account | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Deferred transaction costs | |||||||||||||||||||
| Other non-current assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities and Stockholders’ Deficit | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Promissory note – related party | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total promissory note – related party | |||||||||||||||||||
| Income taxes payable | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||||
| Excise tax payable | |||||||||||||||||||
| Convertible notes, current | |||||||||||||||||||
| Nonrelated Party | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total convertible notes, current | |||||||||||||||||||
| Related party convertible notes, current | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total related party convertible notes, current | |||||||||||||||||||
| Operating lease liabilities, current | |||||||||||||||||||
| Share-based termination liability | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Deferred underwriting fee payable | |||||||||||||||||||
| Warrant liabilities | |||||||||||||||||||
| Operating lease liabilities, non-current | |||||||||||||||||||
| Long-term debt, non-current | |||||||||||||||||||
| Long-term debt, non-current | |||||||||||||||||||
| Warrants | |||||||||||||||||||
| Public placement warrant liability | |||||||||||||||||||
| Related party private placement warrant liability | |||||||||||||||||||
| Convertible preferred stock warrants liability | |||||||||||||||||||
| Total warrants | |||||||||||||||||||
| Related party private placement warrant liability | |||||||||||||||||||
| Convertible preferred stock warrant liability | |||||||||||||||||||
| Other non-current liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Convertible preferred stock: $0.0001 par value, none and 12,550,441 shares authorized as of December 31, 2024 and December 31, 2023, respectively; none and 8,048,573 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively; and aggregate liquidation preference of none and $222,345 as of December 31, 2024 and December 31, 2023, respectively | |||||||||||||||||||
| Convertible Preferred Stock | |||||||||||||||||||
| Total convertible preferred stock: $0.0001 par value, none and 12,550,441 shares authorized as of December 31, 2024 and December 31, 2023, respectively; none and 8,048,573 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively; and aggregate liquidation preference of none and $222,345 as of December 31, 2024 and December 31, 2023, respectively | |||||||||||||||||||
| Stockholders’ Deficit: | |||||||||||||||||||
| Common stock: $0.0001 par value, 500,000,000 shares authorized at September 30, 2025 and December 31, 2024; 3,706,197 and 1,714,792 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | |||||||||||||||||||
| Class A Common Stock | |||||||||||||||||||
| Class B Common Stock | |||||||||||||||||||
| Total common stock: $0.0001 par value, 500,000,000 shares authorized at September 30, 2025 and December 31, 2024; 3,706,197 and 1,714,792 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | |||||||||||||||||||
| Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 140,000 shares and 7,187,500 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ deficit | |||||||||||||||||||
| Total liabilities and stockholders’ deficit | |||||||||||||||||||
Loading...